rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

Glass House Brands Inc. Subordinate Voting Shares

GLAS · NYSE

Health CarePharmaceuticalsNot moving yet

GLAS stood above a rising 150-day average in 37 of the last 52 weekly readings, and has been out of that trend for the last 7 weeks. It is 65.9% below that average now. Pharmaceuticals: 31% of its 74 stocks in an uptrend (−7 points in four weeks); Health Care: 25% (−11 points in four weeks).

Statistics

Rotation
Not moving yet
Weeks in an uptrend
out for 7
Industry in uptrend
31% -7 in 4 wk
Insider buys, 12 months
$0
Insider sales, 12 months
$708K
Officials’ trades on record
1
Institutions holding
50 (+48)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 37 of 52 weeks.

17 Apr – 16 Oct
26%36%46%Apr 26Jun 26Jul 26Sep 26Oct 26

Pharmaceuticals: A minority of its stocks are in an uptrend and the share has been slipping. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026
−$623K$0Nov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

1 disclosed lines: House 1, Senate 0, executive 0; 1 people.

WhoDidAmountTraded
Max L. Miller House: U.S. House ClerkOH07bought$1k–$15k26 Nov 2024filed 5 Dec 2024

Insiders

Buy orders, 12 months0
Sale orders, 12 months4
Buyers · sellers0 · 1
WhoDidSharesTraded
William TuSVP, Corporate Controllersold3,818at $8.0311 Sep 2026filed 11 Sep 2026
William TuSVP, Corporate Controllersold5,423at $10.4826 May 2026filed 26 May 2026
William TuSVP, Corporate Controllersold10,414at $10.1922 May 2026filed 26 May 2026
William TuSVP, Corporate Controllersold15,888at $10.0819 May 2026filed 20 May 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders50+48 on the quarter
New · exited48 · 0
Reported value$238.4M

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
Park West Asset Management LLCnew · filed 14 Aug 20265,182,030$67.4M+5,182,030
Western Standard LLCnew · filed 10 Aug 20262,728,768$35.0M+2,728,768
NOMURA HOLDINGS INCnew · filed 14 Aug 20262,283,439$29.7M+2,283,439
CANTOR FITZGERALD, L. P.new · filed 14 Aug 20261,350,000$16.7M+1,350,000
WELLINGTON MANAGEMENT GROUP LLPnew · filed 14 Aug 20261,145,088$14.9M+1,145,088
AdvisorShares Investments LLCnew · filed 11 Aug 2026850,000$11.1M+850,000
Clear Street Group Inc.new · filed 12 Aug 2026825,000$10.2M+825,000
Hudson Bay Capital Management LPnew · filed 14 Aug 2026750,000$9.8M+750,000
Marex Group Ltdnew · filed 14 Aug 2026750,000$9.8M+750,000
GRIZZLYROCK CAPITAL, LLCnew · filed 14 Aug 2026611,000$7.9M+611,000
31 Mar 2023 – 30 Jun 2026
32648Mar 23Dec 23Dec 24Sep 25Jun 26

News

No headline names it lately.

Everyone who traded it

William Tu Company insiderSVP, Corporate Controller · last 16 Sep 20260 · 4
Max L. Miller HouseOH07 · last 26 Nov 20241 · 0

Same industry

ABBV AbbVieLeading+20%
VTRS ViatrisLeading+16%

Distance from each stock’s own 150-day average.

Government contracts

No federal award is tied to it.

From its SEC filings

Profit per saleFY 2025 · to 31 Dec 202542.3%
Operating profit marginFY 2025 · to 31 Dec 2025-9.1%
Free cash flow marginFY 2025 · to 31 Dec 2025-8.6%
Return on capital employedFY 2025 · to 31 Dec 2025-5.9%
Debt to equityFY 2025 · to 31 Dec 20250.93×
Revenue growthFY 2025 · to 31 Dec 2025-9.4%
Share count trendFY 2025 · to 31 Dec 20258.9%
Cash and equivalentsFY 2025 · to 31 Dec 2025$23.4M
Free cash flowFY 2025 · to 31 Dec 2025−$15.7M

Analyst forecasts

No analyst forecasts yet.